PP London Sumatra Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? PP London Sumatra Indonesia Tbk. trades at Rp1,700 (market cap 11.49T, 15.99M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: PP London Sumatra Indonesia Tbk. is far larger — about 110.1× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| LSIP | SCPI | |
|---|---|---|
Market Cap | 11.49T | 104.4B |
Volume | 15.99M | — |
Lot | 159.9K | — |
Turnover | 27.34B | — |
Average Price | 1,710.03 | — |
Value | 27.34B | — |
Indicative Equilibrium Price | 1,700 | — |
Indicative Equilibrium Volume | 2.92K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Perusahaan Perkebunan London Sumatera Tbk abbreviated as Lonsum, was established in teh Republic of Indonesia based on Notarial Deed No. 93 of Raden Kadiman dated December 18, 1962 and amended by Notarial Deed No. 20 dated September 9, 1963. Based on Notarial Deed No. 18 of Pahala Sutrisno Amijoyo Tampubolon, S.H., M.Kn., dated May 24, 2013, the Company's shareholders approved the change of the Company's status from Foreign Capital Investment (PMA) company to Domestic Capital Investment (PMDN) company.
Read more on LSIP →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →